LONG TERM OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS: THE ROLE OF MINIMAL RESIDUAL DISEASE

被引：0

作者：

Paolini, S. ^{[1
]}

Romani, L. ^{[1
]}

Ottaviani, E. ^{[1
]}

Marconi, G. ^{[1
]}

Papayannidis, C. ^{[1
]}

Parisi, S. ^{[1
]}

Sartor, C. ^{[1
]}

Nanni, J. ^{[1
]}

Cristiano, G. ^{[1
]}

Abbenante, M. C. ^{[1
]}

Talami, A. ^{[1
]}

Olivi, M. ^{[1
]}

Ragaini, S. ^{[1
]}

Bandini, L. ^{[1
]}

Venturi, C. ^{[1
]}

Raffini, M. ^{[1
]}

Robustelli, V. ^{[1
]}

Martinelli, G. ^{[1
]}

Testoni, N. ^{[1
]}

Baldazzi, C. ^{[1
]}

Cavo, M. ^{[1
]}

Curti, A. ^{[1
]}

机构：

[1] Univ Bologna, Ist Ematol L&A Seragnoli, Dipartimento Med Specialist Diagnost & Sperimenta, IRCCS Casa Sollievo Della Sofferenza,Ist Sci Roma, Bologna, Italy

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C080

引用

页码：46 / 46

页数：1

共 50 条

[1] Minimal residual disease (MRD) monitoring after autologous stem cell transplantation (auSCT) in acute myeloid leukemia (AML).
Venditti, A
Buccisano, F
Del Poeta, G
Tamburini, A
Maurillo, L
Postorino, M
Picardi, A
Riccitelli, A
Amadori, S
BLOOD, 2000, 96 (11) : 311A - 311A
[2] Prognostic impact of minimal residual disease assessed by immunophenotype in patients with acute myeloid leukemia undergoing autologous stem cell transplantation.
Lahuerta, JJ
Montalban, MA
Grande, C
Larregla, S
Toscano, R
Ortiz, MC
Martín, ML
Bornstien, R
de la Serna, J
BLOOD, 1998, 92 (10) : 367B - 367B
[3] MINIMAL RESIDUAL DISEASE PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA AS A PREDICTOR OF RELAPSE
Rojas, A. M.
Song, S. X.
Corliss, A.
Truell, J.
Paquette, R. L.
Schiller, G. J.
Territo, M. C.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 59 - 59
[4] Autologous stem cell transplantation in patients with acute myeloid leukemia is relatively safe and provides long-term disease control
Ganguly, S
Divine, CL
Deauna-Limayo, D
Bodensteiner, DC
Lewis, JL
Curran, K
Skikne, BS
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 100 - 100
[5] Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
A Venditti
L Maurillo
F Buccisano
G Del Poeta
C Mazzone
A Tamburini
M I Del Principe
M I Consalvo
P De Fabritiis
L Cudillo
A Picardi
A Franchi
F L Coco
S Amadori
Leukemia, 2003, 17 : 2178 - 2182
[6] Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
Venditti, A
Maurillo, L
Buccisano, F
Del Poeta, G
Mazzone, C
Tamburini, A
Del Principe, MI
Consalvo, MI
De Fabritiis, P
Cudillo, L
Picardi, A
Franchi, A
Coco, FL
Amadori, S
LEUKEMIA, 2003, 17 (11) : 2178 - 2182
[7] Is there still a role for autologous stem cell transplantation in acute myeloid leukemia?
Al Sabty, F.
Demeckova, E.
Bojtarova, E.
Hrubisko, M.
Mistrik, M.
NEOPLASMA, 2013, 60 (02) : 167 - 173
[8] Autologous hematopoietic stem cell transplantation in acute myeloid leukaemia: Long-term outcome
Sharif, Azizan
Mui, Tan Sen
Chuan, Ong Tee
Kadir, Sharifah Shahnaz Syed Abdul
Wah, Ho Kim
Boon, Law Kian
BONE MARROW TRANSPLANTATION, 2019, 54 : 376 - 376
[9] Monitoring of minimal residual disease after autologous stem cell transplantation in adult AML patients
Maurillo, L
Tamburini, A
Buccisano, F
Del Principe, MI
Venditti, A
Del Poeta, G
De Fabritiis, P
Amadori, S
BONE MARROW TRANSPLANTATION, 2003, 31 : S122 - S123
[10] Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
A Venditti
L Maurillo
F Buccisano
G Del Poeta
C Mazzone
A Tamburini
M I Del Principe
M I Consalvo
P De Fabritiis
L Cudillo
A Picardi
A Franchi
F L Coco
S Amadori
Leukemia, 2004, 18 : 373 - 373

← 1 2 3 4 5 →